Steven Cook Sells 33,000 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 33,000 shares of the stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $19.89, for a total transaction of $656,370.00. Following the completion of the sale, the chief financial officer owned 133,359 shares in the company, valued at $2,652,510.51. This represents a 19.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Omada Health Stock Up 1.3%

NASDAQ OMDA traded up $0.28 during trading on Tuesday, reaching $21.95. 853,685 shares of the stock traded hands, compared to its average volume of 1,070,637. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92. The stock’s 50-day moving average price is $16.83 and its 200 day moving average price is $14.93.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. The company had revenue of $78.05 million for the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. Analysts expect that Omada Health, Inc. will post -0.01 EPS for the current year.

Wall Street Analysts Forecast Growth

OMDA has been the topic of several recent analyst reports. JPMorgan Chase & Co. reduced their target price on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a report on Thursday, March 12th. Morgan Stanley restated an “overweight” rating and issued a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Citizens Jmp raised their price target on Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research report on Friday, May 8th. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Barclays boosted their price objective on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $22.91.

Institutional Investors Weigh In On Omada Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Quarry LP acquired a new position in Omada Health in the 4th quarter worth $29,000. TD Waterhouse Canada Inc. acquired a new stake in shares of Omada Health in the 4th quarter valued at about $32,000. Raymond James Financial Inc. bought a new stake in shares of Omada Health in the second quarter valued at about $32,000. Inlight Wealth Management LLC acquired a new position in shares of Omada Health during the fourth quarter worth about $45,000. Finally, Strs Ohio boosted its position in shares of Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after buying an additional 2,567 shares during the period.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.